Eshmuminov, Dilmurodjon
Becker, Dustin
Hefti, Max L.
Mueller, Matteo
Hagedorn, Catherine
Dutkowski, Philipp
Rudolf von Rohr, Philipp
Halbe, Maximilian
Segerer, Stephan
Tibbitt, Mark W.
Bautista Borrego, Lucia
Schuler, Martin J.
Clavien, Pierre-Alain
Article History
Received: 7 May 2020
Accepted: 18 November 2020
First Online: 1 December 2020
Competing interests
: ETH (Swiss Federal Institute of Technology in Zurich) and the University of Zurich (D.E., D.B., L.B.B., M. L. H., M. J. S., P.D., P. RvR., and P-A. C.) have applied for a patent on this perfusion technology. PCT/EP2019/051252. Stephan Segerer receives financial support and travel expenses as a Speaker from Baxter and Fresenius. He is medical advisor for Peripal and Versantis. These are not related to the current study.